Greenwich LifeSciences, Inc. is a clinical stage biopharmaceutical company. The Company is developing, GP2, a breast cancer immunotherapy focused on preventing the recurrence of breast cancer following surgery. GP2 is a nine amino acid transmembrane ... Read more